TegoSens
TegoSens is developing a universally adoptable, non-invasive, and portable device that provides early actionable detection of direct lung tissue specific fluid levels in patients, driving guideline-based therapies for specific conditions such as heart failure. The TegoSens solution is extremely competitive, yet complementary to existing diagnostic offerings and addresses a significant unmet need for the management of patients at point of care and home.
In the News
Ikove and its portfolio of companies are making noise with groundbreaking innovation.
